| Phytochemical Name | Atractylenolide-III |
| PubChem CID | 155948 |
| Disease Indication | Sepsis [ICD-11: 1G40] Investigative |
| Clinical Trials | |
| Interaction Partner | Anticancer drug Name: Docetaxel |
| Source |
Warm
Atractylodes macrocephala
|
| Phytochemical Name | Atractylenolide I |
| PubChem CID | 5321018 |
| Disease Indication | Intestinal adenoma [ICD-11: 2E92] Investigative |
| Clinical Trials | |
| Interaction Partner | Anticancer drug Name: Cabozantinib; Erlotinib |
| Source |
Warm
Atractylodes macrocephala;
Atractylodes lancea
Even
Poria cocos;
Poria cocos;
|
| Phytochemical Name | Luteolin |
| PubChem CID | 5280445 |
| Disease Indication | Autism spectrum disorders [ICD-11: 6A02] Phase 2 |
| Clinical Trials | |
| Interaction Partner | Anticancer drug Name: Bortezomib; Celecoxib; Cisplatin; Erastin; Erlotinib; Fluorouracil; Gefitinib; Gemcitabine; IL-24; Imatinib; Lapatinib; Osimertinib; Oxaliplatin; Paclitaxel; SMC3; Sorafenib; TNF-related apoptosis inducing ligand; Tamoxifen |
| Source |
Cold
Taraxacum mongolicum
|
| Phytochemical Name | Chicoric acid |
| PubChem CID | 5281764 |
| Disease Indication | Sepsis [ICD-11: 1G40] Investigative |
| Clinical Trials | |
| Interaction Partner | Anticancer drug Name: TNF-related apoptosis inducing ligand |
| Source |
Cool
Cichorium glandulosum;
Cold
Viola yedoensis;
Taraxacum mongolicum
Unknown
Annona cherimolia;
|
| Phytochemical Name | Dihydroartemisinin |
| PubChem CID | 3000518 |
| Disease Indication | Solid tumour or cancer [ICD-11: 2A00-2F9Z] Investigative |
| Clinical Trials | |
| Interaction Partner | Anticancer drug Name: Capecitabine; Cisplatin; Doxorubicin; Gefitinib; Osimertinib; Oxaliplatin; Sorafenib |
| Source |
Cold
Artemisia annua
|
| Phytochemical Name | Artesunate |
| PubChem CID | 6917864 |
| Disease Indication | Colorectal cancer [ICD-11: 2B91.Z] Phase 2 |
| Clinical Trials | |
| Interaction Partner | Anticancer drug Name: Cisplatin; Fluorouracil; Metformin; Nevirapine; Sorafenib; TP-0903; Venetoclax |
| Source |
Cold
Artemisia annua;
Artemisia annua
|
| Phytochemical Name | Luteolin |
| PubChem CID | 5280445 |
| Disease Indication | Autism spectrum disorders [ICD-11: 6A02] Phase 2 |
| Clinical Trials | |
| Interaction Partner | Anticancer drug Name: Bortezomib; Celecoxib; Cisplatin; Erastin; Erlotinib; Fluorouracil; Gefitinib; Gemcitabine; IL-24; Imatinib; Lapatinib; Osimertinib; Oxaliplatin; Paclitaxel; SMC3; Sorafenib; TNF-related apoptosis inducing ligand; Tamoxifen |
| Source |
Cold
Taraxacum mongolicum
|
| Phytochemical Name | Chicoric acid |
| PubChem CID | 5281764 |
| Disease Indication | Sepsis [ICD-11: 1G40] Investigative |
| Clinical Trials | |
| Interaction Partner | Anticancer drug Name: TNF-related apoptosis inducing ligand |
| Source |
Cool
Cichorium glandulosum;
Cold
Viola yedoensis;
Taraxacum mongolicum
Unknown
Annona cherimolia;
|
| Phytochemical Name | Luteolin |
| PubChem CID | 5280445 |
| Disease Indication | Autism spectrum disorders [ICD-11: 6A02] Phase 2 |
| Clinical Trials | |
| Interaction Partner | Anticancer drug Name: Bortezomib; Celecoxib; Cisplatin; Erastin; Erlotinib; Fluorouracil; Gefitinib; Gemcitabine; IL-24; Imatinib; Lapatinib; Osimertinib; Oxaliplatin; Paclitaxel; SMC3; Sorafenib; TNF-related apoptosis inducing ligand; Tamoxifen |
| Source |
Cold
Taraxacum mongolicum
|
| Phytochemical Name | Chicoric acid |
| PubChem CID | 5281764 |
| Disease Indication | Sepsis [ICD-11: 1G40] Investigative |
| Clinical Trials | |
| Interaction Partner | Anticancer drug Name: TNF-related apoptosis inducing ligand |
| Source |
Cool
Cichorium glandulosum;
Cold
Viola yedoensis;
Taraxacum mongolicum
Unknown
Annona cherimolia;
|
